Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

BUY
$0.13 - $76.84 $456 - $269,554
3,508 New
3,508 $249,000
Q2 2021

Jul 20, 2021

SELL
$61.91 - $67.42 $1.39 Million - $1.51 Million
-22,382 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $668,880 - $752,293
-11,272 Reduced 33.49%
22,382 $1.41 Million
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $1.94 Million - $2.2 Million
33,654 New
33,654 $2.09 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northstar Advisory Group, LLC Portfolio

Follow Northstar Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Advisory Group, LLC with notifications on news.